These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9581222)

  • 1. Alzheimer's disease. Cholinergic therapy and beyond.
    Sunderland T
    Am J Geriatr Psychiatry; 1998; 6(2 Suppl 1):S56-63. PubMed ID: 9581222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status: Alzheimer's Disease.
    Ghosh R
    Kathmandu Univ Med J (KUMJ); 2003; 1(3):205-11. PubMed ID: 16388232
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in the management of Alzheimer's disease.
    Smith AL; Whitehouse PJ
    Hosp Pract (1995); 1998 Mar; 33(3):151-4, 157-66. PubMed ID: 9522840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: emerging trends in small molecule therapies.
    Mohamed T; Rao PP
    Curr Med Chem; 2011; 18(28):4299-320. PubMed ID: 21861820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dementias: present situation and future perspectives (III). Neurological, therapeutic, psychosocial aspects and patient care].
    Espert R; Bertolín JM; Navarro JF; González A
    Rev Neurol; 1995; 23(119):86-95. PubMed ID: 8548650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update.
    Weinstock M
    Neurodegeneration; 1995 Dec; 4(4):349-56. PubMed ID: 8846227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M; Kálmán J
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies.
    Cummings JL
    Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment for non-cognitive symptoms in Alzheimer's disease].
    Vilalta-Franch J; López-Pousa S; Llinàs-Reglà J
    Rev Neurol; 1999 Nov 1-15; 29(9):819-24. PubMed ID: 10696656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.
    Lahiri DK; Rogers JT; Greig NH; Sambamurti K
    Curr Pharm Des; 2004; 10(25):3111-9. PubMed ID: 15544501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metrifonate: a new agent for the treatment of Alzheimer's disease.
    Williams BR
    Am J Health Syst Pharm; 1999 Mar; 56(5):427-32. PubMed ID: 10096702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging therapies for Alzheimer's disease.
    Nygaard HB
    Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
    Robert P
    Curr Med Res Opin; 2002; 18(3):156-71. PubMed ID: 12094826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of therapies for Alzheimer's disease based on cholinergic hypothesis-status quo and future directions].
    Shimohama S
    Rinsho Shinkeigaku; 2013; 53(11):1036-8. PubMed ID: 24291871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Alzheimer's Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions.
    Ashford JW
    J Alzheimers Dis; 2015; 47(1):149-56. PubMed ID: 26402763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationalizing therapeutic approaches in Alzheimer's disease.
    Grossberg GT
    CNS Spectr; 2005 Nov; 10(11 Suppl 18):17-21. PubMed ID: 16273026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and emerging treatments for Alzheimer's disease.
    Corbett A; Smith J; Ballard C
    Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Alzheimer therapy: cholinesterase inhibitors.
    Ashford JW; Sherman KA; Kumar V
    Neurobiol Aging; 1989; 10(1):99-105. PubMed ID: 2755560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.